Journal
NATURE IMMUNOLOGY
Volume 10, Issue 2, Pages 167-175Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ni.1690
Keywords
-
Categories
Funding
- National Institutes of Health [1R01NS045937-01, 2R01NS35685-06, 2R37NS30843-11, 1R01A144880-03, P01NS38037-04, 1R01NS046414, 2P01A139671-07, 1P01AI56299, R37 AI38310]
- Javits Neuroscience Investigator Award
- National Multiple Sclerosis Society [RG-2571-D-9]
- European Commission
- Deutsche Forschungsgemeinschaft
Ask authors/readers for more resources
The inducible costimulatory molecule ICOS has been suggested to be important in the development of interleukin 17 (IL-17)producing helper T cells (T-H-17 cells) and of follicular helper T cells (T-FH cells). Here we show that ICOS-deficient mice had no defect in T-H-17 differentiation but had fewer T-H-17 cells after IL-23 stimulation and fewer TFH cells. We also show that TFH cells produced IL-17 and that TFH cells in ICOS-deficient mice were defective in IL-17 production. Both T-H-17 and TFH cells had higher expression of the transcription factor c-Maf. Genetic loss of c-Maf resulted in a defect in IL-21 production and fewer T-H-17 and T-FH cells. Thus our data suggest that ICOS-induced c-Maf regulates IL-21 production that in turn regulates the expansion of T-H-17 and T-FH cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available